If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
167
Followers on Owler
Ncardia
is a drug discovery and developing stem cell technology company that produces and commercializes cardiovascular and neuronal cell types...
Read more
Overview
Competitors
Funding
News & Insights
Ncardia
is a drug discovery and developing stem cell technology company that produces and commercializes cardiovascular and neuronal cell types...
Read more
CEO
Stefan Braam
CEO Approval Rating
88/100
Weigh In
2017
Leiden
Other
Private
Pharmaceuticals & Biotechnology
Biotechnology
2836
NAICS listing
http://ncardia.com/
Est. Annual Revenue
$100K-5.0M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
Funding
$72.4M
News
Latest News
Sep 25, 2025
Pharmabiz
Ncardia: Ncardia launches Ncyte NHPC vCardiomyocytes to advance cardiac safety research
Jan 27, 2025
FinanzNachrichten
Ncardia: Ncardia Launches Ncyte Microglia to Advance Research in Neurodegenerative Diseases
Sep 10, 2024
Benzinga
Ncardia: Ncardia Launches Panel of Ready-to-Use Assays to Streamline Screening and Selection of New Therapeutic Candidates
Jan 05, 2023
BioSpace
Ncardia: Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth
Nov 22, 2022
EIN Presswire
Press Release: Ncardia : Prepaire Announces Partnership With Ncardia To Accelerate Plans To Discover New Drugs & Repurpose Existing Libraries
Apr 19, 2022
FirstWord Pharma
Ncardia: Ncardia Launches Cellistic, the Only iPSC-based Cell Therapy Process Development & Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today
Feb 24, 2022
Medical, Marketing and Media
Ncardia: Ncardia hires Holt as chief commercial officer
Nov 26, 2021
Global Legal Chronicle
Ncardia: Kiniciti's Investment in Ncardia
Nov 25, 2021
BioPharma-Reporter
Ncardia: Ncardia secures $60m to expand iPSC platform
Nov 19, 2021
Endpoints News
Ncardia: Stem cell specialist Ncardia bags new funds to help scale manufacturing ops
Follow and Get Alerts
Ncardia Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 26 + competitors
Trending Companies